TBC1D31 and cancer: Again, TCGA pan‐cancer analyses showed that higher TBC1D31 mRNA levels are correlated with the advanced clinical stages (Figure S3e, Supporting Information), and poor OS or DFS rates in patients with several other types of cancer (Figure S3f, Supporting Information).